Markus Lassila
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Papers in
- Nephrology 12
- Renal Diseases and Glomerulopathies 10
- Chronic Kidney Disease and Diabetes 6
-
- Advanced Glycation End Products research 4
- Co-authors
- Mark E. CooperKarin Jandeleit‐DahmTerri J. AllenRiccardo CandidoVicki ThallasZemin CaoJosephine M. ForbesAnna C. Calkin
In The Last Decade
Markus Lassila
33 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 86
- Clinical Biochemistry 358
- Nephrology 309
- Endocrinology, Diabetes and Metabolism 412
- Transplantation 49
- Cardiology and Cardiovascular Medicine 331
Countries citing papers authored by Markus Lassila
This map shows the geographic impact of Markus Lassila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Lassila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Lassila more than expected).
Fields of papers citing papers by Markus Lassila
This network shows the impact of papers produced by Markus Lassila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Lassila. The network helps show where Markus Lassila may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Lassila, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2009 | 21 | |
| 4 | 2008 | 18 | |
| 5 | 2007 | 36 | |
| 6 | 2007 | 23 | |
| 7 | 2007 | 15 | |
| 8 | 2006 | 11 | |
| 9 | 2006 | 20 | |
| 10 | 2005 | 98 | |
| 11 | 2005 | 37 | |
| 12 | 2004 | 116 | |
| 13 | 2004 | 11 | |
| 14 | 2004 | 173 | |
| 15 | 2002 | 55 | |
| 16 | 2002 | 26 | |
| 17 | 2002 | 21 | |
| 18 | 2001 | 34 | |
| 19 | 2000 | 42 | |
| 20 | 2000 | 4 |
About Markus Lassila
Markus Lassila is a scholar working on Nephrology, Clinical Biochemistry, Physiology, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 34 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (10 papers), Chronic Kidney Disease and Diabetes (6 papers), Renin-Angiotensin System Studies (4 papers), Advanced Glycation End Products research (4 papers), Neurological Complications and Syndromes (3 papers), Renal and related cancers (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Clinical Biochemistry (358 citations), Nephrology (309 citations), Endocrinology, Diabetes and Metabolism (412 citations), Transplantation (49 citations) and Cardiology and Cardiovascular Medicine (331 citations). Markus Lassila has collaborated with scholars based in Finland, Australia and Italy. Frequent co-authors include Mark E. Cooper, Karin Jandeleit‐Dahm, Terri J. Allen, Riccardo Candido, Vicki Thallas, Zemin Cao, Josephine M. Forbes, Anna C. Calkin, Merlin C. Thomas and Wendy C. Burns. Their work appears in journals such as Journal of the American Society of Nephrology, Journal of Hypertension, European Journal of Pharmacology, Molecular and Cellular Biochemistry and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.